CClinicalTrials.gg
CompletedNCT04836039Updated Apr 8, 2021

Rehabilitation Experiences of Physiotherapists in Covid-19 Outbreak

An observational study in Physical Therapy, sponsored by Medipol University. Completed at 1 site in Turkey. Open to participants aged 22 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-04-08.

Sponsored by Medipol University · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
400
Ages
22 Years to 65 Years
Sex
All
01

Study summary

The aim of this study is to evaluate the process experienced by physiotherapists while providing rehabilitation services during the epidemic and to investigate the procedures adopted by physiotherapists who are currently working. In addition, by analyzing the effects of both the pandemic and the clinical and educational organizations in the Physiotherapy and Rehabilitation Clinics where physiotherapists were working during the COVID-19 epidemic, the needs arising after the pandemic can be reported. Assessments will be carried out by researcher physiotherapists through a questionnaire based on research and examples in the literature, and scales measuring anxiety, depression and stress levels. The measurement tool will be the online survey application.

Read the detailed description

The aim of this study is to evaluate the process experienced by physiotherapists while providing rehabilitation services during the epidemic and to investigate the procedures adopted by physiotherapists who are currently working.

In addition, by analyzing the effects of both the pandemic and the clinical and educational organizations in the Physiotherapy and Rehabilitation Clinics where physiotherapists were working during the COVID-19 epidemic, the needs arising after the pandemic can be reported.

Assessments will be carried out by researcher physiotherapists through a questionnaire based on research and examples in the literature, and scales measuring anxiety, depression and stress levels. The measurement tool will be the online survey application.

Data collection is planned to take place in February-March 2021.

Surveys will be distributed via WhatsApp, e-mail, social media links. This questionnaire was sent to 3 physiotherapists and subjected to a pre-test. This questionnaire is about the following situations and contains 37 questions:

Information on employment status: In this section, physiotherapists' name-surname, gender, age, professional practice experience (years), generally applied physiotherapy subgroup (more than one can be selected), whether they are self-employed or employees, and the status of performing face-to-face clinical practices will be questioned. If so, it will be questioned which protection measures have been applied.

Information about tele-rehabilitation practices: In this section, it will be questioned whether physiotherapists start to follow their patients remotely, if they are, in what way they do it, whether the number of weekly sessions continues, and whether the amount collected is the same as the face-to-face amount.

General information about COVID 19 rehabilitation: In this section, did the departments where physiotherapists work returned to COVID 19 services, did they work in COVID 19 units, rehabilitation approaches in COVID 19 patients, protocol and / or guidelines on exercises for rehabilitation management and treatment of COVID 19 patients. material development / implementation status will be questioned.

The impact of the pandemic on the health and teaching activities of physiotherapists and the sustainability of clinical / thesis studies during this period will be questioned.

Finally, the CES Depression Scale (Center for Epidemiologic Studies Depression Scale, CES-D) will be used to determine depression level, the Generalized Anxiety Disorder 7 (GAD-7) Test will be used to evaluate generalized anxiety level, Perceived Stress Scale (PSS) will be used to determine stress level.

02

Conditions studied

  • Physical Therapy
03

In context

Lead sponsor

Medipol University is the lead sponsor of 311 studies on the registry; 86 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
22 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Individuals between the ages of 22-65 who continue to work as a self-employed or employee physiotherapist.

Inclusion criteria

Individuals between the ages of 22-65 who continue to work as a self-employed or employee physiotherapist.

Exclusion criteria

Exclusion Criteria:

Not meeting the inclusion criteria

05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
400 participants (actual)
Patient registry
No

Groups and cohorts

  • Physiotherapists

    Individuals between the ages of 22-65 who continue to work as a self-employed or employee physiotherapist.

    Other: A questionnaire and scales.

Interventions

  • OtherA questionnaire and scales.

    Participants will be evaluated by applying a questionnaire and scales created by the researcher physiotherapists based on the researches and examples in the literature.

06

What researchers measure

Primary outcomes

  1. A questionnaire created by research physiotherapists based on researches and examples in the literature.

    Participants will be evaluated by applying a questionnaire and scales created by the researcher physiotherapists based on the researches and examples in the literature.

    Time frame: The evaluation will take place in one interview (the interview will take 30 minutes)

Secondary outcomes

  1. Assessment of depression level with Center for Epidemiologic Studies Depression Scale

    The Center for Epidemiologic Studies Depression Scale will be used to determine depression level. The scale consists of 20 questions in the form of a self-report that measure the emotional state of the person in depression, perceptions and behaviors towards depression. 4-point Likert type questionnaire with 0-60 points range is encoded in 0-3 points range.

    Time frame: The evaluation will take place in one interview (the interview will take 30 minutes)

  2. Assessment of anxiety level with Generalized Anxiety Disorder 7 Test

    The Generalized Anxiety Disorder 7 test will be used to determine anxiety level. It is a 7-item four-point Likert (0 = none, 1 = many days, 2 = more than half of the days, 3 = almost every day), which evaluates the experiences asked in the scale items in the last 2 weeks. The total scores obtained from the scale are 5, 10, and 15 cut-off points for mild, moderate, and severe anxiety, respectively.

    Time frame: The evaluation will take place in one interview (the interview will take 30 minutes)

  3. Assessment of stress level with Perceived Stress Scale

    Perceived Stress Scale will be used to determine stress level. Participants rate how often their lives were seen as unpredictable, uncontrollable, and overly intense during the previous month on the 5-point Likert scale (0 = Never, 4 = Very often). Total scores range from 0 to 40, with higher scores indicating a higher perceived stress level.

    Time frame: The evaluation will take place in one interview (the interview will take 30 minutes)

07

Study locations

1 site
  • Medipol University
    Istanbul, Beykoz 34815, Turkey
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 8, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04836039
Lead sponsor
Medipol University
Responsible party
Pınar Ciddi (Assistant Professor, Medipol University) — Principal investigator
First posted
Apr 8, 2021
Start date
Jan 27, 2021
Primary completion
Feb 27, 2021
Completion
Feb 27, 2021
Last update
Apr 8, 2021

Study contacts

Gülay Aras Bayram, asAss. Prof.
study chair · Medipol University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion